Literature DB >> 17671178

Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates.

David Gius1, Margo C Funk, Eric Y Chuang, Sheng Feng, Phyllis C Huettner, Loan Nguyen, C Matthew Bradbury, Mark Mishra, Shuping Gao, Barbara M Buttin, David E Cohn, Matthew A Powell, Neil S Horowitz, Bradford P Whitcomb, Janet S Rader.   

Abstract

This study is the first comprehensive, integrated approach to examine grade-specific changes in gene expression along the entire neoplastic spectrum of cervical intraepithelial neoplasia (CIN) in the process of cervical carcinogenesis. This was accomplished by identifying gene expression signatures of disease progression using cDNA microarrays to analyze RNA from laser-captured microdissected epithelium and underlying stroma from normal cervix, graded CINs, cancer, and patient-matched normal cervical tissues. A separate set of samples were subsequently validated using a linear mixed model that is ideal to control for interpatient gene expression profile variation, such as age and race. These validated genes were ultimately used to propose a genomically based model of the early events in cervical neoplastic transformation. In this model, the CIN 1 transition coincides with a proproliferative/immunosuppression gene signature in the epithelium that probably represents the epithelial response to human papillomavirus infection. The CIN 2 transition coincides with a proangiogenic signature, suggesting a cooperative signaling interaction between stroma and tumor cells. Finally, the CIN 3 and squamous cell carcinoma antigen transition coincide with a proinvasive gene signature that may be a response to epithelial tumor cell overcrowding. This work strongly suggests that premalignant cells experience a series of microenvironmental stresses at the epithelium/stroma cell interface that must be overcome to progress into a transformed phenotype and identifies the order of these events in vivo and their association with specific CIN transitions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671178     DOI: 10.1158/0008-5472.CAN-07-0260

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

1.  Identification of differential expressed transcripts in cervical cancer of Mexican patients.

Authors:  Leticia Santos; Ma Fabiola León-Galván; Erika Nahomy Marino-Marmolejo; Ana Paulina Barba de la Rosa; Antonio De León Rodríguez; Roberto González-Amaro; Ramón Gerardo Guevara-González
Journal:  Tumour Biol       Date:  2011-01-13

2.  Detection of cervical cancer based on photoacoustic imaging-the in-vitro results.

Authors:  Kuan Peng; Ling He; Bo Wang; Jiaying Xiao
Journal:  Biomed Opt Express       Date:  2014-12-15       Impact factor: 3.732

3.  The Value of a Novel Panel of Cervical Cancer Biomarkers for Triage of HPV Positive Patients and for Detecting Disease Progression.

Authors:  Norbert Varga; Johanna Mózes; Helen Keegan; Christine White; Lynne Kelly; Loretto Pilkington; Márta Benczik; Schaff Zsuzsanna; Gábor Sobel; Róbert Koiss; Edit Babarczi; Miklos Nyíri; Laura Kovács; Sebe Attila; Borbála Kaltenecker; Adrienn Géresi; Adrienn Kocsis; John O'Leary; Cara M Martin; Csaba Jeney
Journal:  Pathol Oncol Res       Date:  2016-08-06       Impact factor: 3.201

4.  Immunosignature system for diagnosis of cancer.

Authors:  Phillip Stafford; Zbigniew Cichacz; Neal W Woodbury; Stephen Albert Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

5.  Suppression of Stromal Interferon Signaling by Human Papillomavirus 16.

Authors:  Gaurav Raikhy; Brittany L Woodby; Matthew L Scott; Grace Shin; Julia E Myers; Rona S Scott; Jason M Bodily
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

6.  Molecular fixative enables expression microarray analysis of microdissected clinical cervical specimens.

Authors:  Gerald Li; Dirk van Niekerk; Dianne Miller; Thomas Ehlen; Cathie Garnis; Michele Follen; Martial Guillaud; Calum Macaulay
Journal:  Exp Mol Pathol       Date:  2014-01-08       Impact factor: 3.362

7.  Tissue-Specific Gene Expression during Productive Human Papillomavirus 16 Infection of Cervical, Foreskin, and Tonsil Epithelium.

Authors:  Sreejata Chatterjee; Sa Do Kang; Samina Alam; Anna C Salzberg; Janice Milici; Sjoerd H van der Burg; Willard Freeman; Craig Meyers
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

8.  A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.

Authors:  Janet S Rader; Michael W Sill; Jan H Beumer; Heather A Lankes; Doris Mangiaracina Benbrook; Francisco Garcia; Connie Trimble; J Tate Thigpen; Richard Lieberman; Rosemary E Zuna; Charles A Leath; Nick M Spirtos; John Byron; Premal H Thaker; Shashikant Lele; David Alberts
Journal:  Gynecol Oncol       Date:  2017-03-10       Impact factor: 5.482

9.  Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue.

Authors:  Enoc M Cortés-Malagón; José Bonilla-Delgado; José Díaz-Chávez; Alfredo Hidalgo-Miranda; Sandra Romero-Cordoba; Aykut Uren; Haydar Celik; Matthew McCormick; José A Munguía-Moreno; Eloisa Ibarra-Sierra; Jaime Escobar-Herrera; Paul F Lambert; Daniel Mendoza-Villanueva; Rosa M Bermudez-Cruz; Patricio Gariglio
Journal:  Virology       Date:  2013-09-27       Impact factor: 3.616

10.  Gene expression profile of cervical and skin tissues from human papillomavirus type 16 E6 transgenic mice.

Authors:  D Mendoza-Villanueva; J Diaz-Chavez; L Uribe-Figueroa; C Rangel-Escareão; A Hidalgo-Miranda; S March-Mifsut; G Jimenez-Sanchez; Pf Lambert; P Gariglio
Journal:  BMC Cancer       Date:  2008-11-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.